ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0539

Clinical Expression of Radiographic Axial Spondyloarthritis and Its Association with HLA-B27 in European and Ibero-American Populations: Data from the REGISPONSER and RESPONDIA Registries

Maria Angeles Puche-Larrubia1, María Lourdes Ladehesa-Pineda2, Pilar Font3, Rubén Burgos Vargas4, Percival Sampaio-Barros5, José Maldonado Cocco6, Anabela Barcelos7, Jordi Gratacos Masmitja8, Xavier Juanola9, Alejandro Escudero-Contreras3, Janitzia Vázquez Mellado4, Iván Arias-de la Rosa10, Eduardo Collantes-Estevez11 and Clementina López Medina12, 1Reina Sofía University Hospital, Cordoba, Spain, 2IMIBIC/Reina Sofia Hospital/University of Cordoba, Cordoba, Andalucia, Spain, 3IMIBIC/Reina Sofia Hospital/University of Cordoba, Cordoba, Spain, 4Department of Rheumatology, Hospital General de México and Faculty of Medicine, Universidad Nacional Autónoma de México, Mexico, Mexico, 5Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, São Paulo, SP, Brazil, 6Rheumatology, Buenos Aires University School of Medicine, Buenos Aires, Argentina, 7Rheumatology Department, Centro Hospitalar do Baixo Vouga, Aveiro, Portugal, 8University Hospital Parc Taulí, Sabadell, Spain, 9Department of Rheumatology, Hospital Universitari de Bellvitge, Barcelona, Spain, 10Rheumatology Service, Maimonides Institute of Biomedical Research of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Cordoba, Spain, 11Rheumatology Service, Maimonides Institute of Biomedical Research of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Cordoba 14012, Spain, 12Reina Sofia University Hospital, Cordoba, Spain

Meeting: ACR Convergence 2024

Keywords: spondyloarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: SpA Including PsA – Diagnosis, Manifestations, & Outcomes Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: To date, few comparative studies have explored how ethnic and geographical differences impact the clinical presentation and management of Spondyloarthritis (SpA). Moreover, no studies have evaluated these differences according to the presence of HLA-B27 which could confirm or refute whether differences in phenotypes between European and Latin American patients are due to the unbalanced distribution of this antigen.

The objective of this study is to compare the sociodemographic and clinical characteristics of Ibero-American patients with radiographic axial SpA (r-axSpA) to those of European patients, with a particular focus on the influence of HLA-B27.

Methods: This was an observational, cross-sectional, and multicentre study of patients who fulfilled the European Spondyloarthropathy Study Group (ESSG) criteria for SpA from the REGISPONSER (Registry of Spondyloarthritis of Spanish Rheumatology) and RESPONDIA (Ibero-American Registry of Spondyloarthropathies) registries. Univariate and multivariate analyses between European and Ibero-American populations stratified by HLA-B27 status were conducted. Race stratification (White, Black American, and Indian American) was also performed to evaluate clinical differences according to HLA-B27.

Results: A total of 2592 patients with a clinical diagnosis of r-axSpA were included in the analysis: 1083 (41.8%) Ibero-American and 1509 (58.2%) European. Among the HLA-B27-positive patients, factors independently associated with Ibero-American patients were the higher use of conventional synthetic disease-modifying antirheumatic drugs (csDMARD) (OR: 4.21), arthritis (OR: 2.36), enthesitis (OR: 6.01), dactylitis (OR: 6.10), severe structural damage (BASRI) (OR: 1.12) and poor functionality (BASFI) (OR: 1.40). Multivariate analysis in HLAB27-negative patients revealed that Ibero-American status was independently associated with enthesitis (OR: 11.67), csDMARDs (OR: 15.51) and total BASRI (OR: 1.34) (Figure 1). Clinical manifestations also varied across racial groups, with differences noted in the prevalence of peripheral joint manifestations such as more arthritis and enthesitis in American Indian patients than in White and Black American patients (Table 1).

Conclusion: Compared with patients from Europe, the Ibero-American r-axSpA patients exhibited more peripheral manifestations, more structural damage, and worse functionality, regardless of the presence of HLA-B27. Along with American Indian patients, Black American patients had a greater prevalence of peripheral manifestations and a greater loss of functionality regardless of HLA-B27 positivity.

Supporting image 1

Figure 1. Factors associated with Ibero-American countries versus European countries


Disclosures: M. Puche-Larrubia: None; M. Ladehesa-Pineda: None; P. Font: None; R. Burgos Vargas: None; P. Sampaio-Barros: None; J. Maldonado Cocco: None; A. Barcelos: None; J. Gratacos Masmitja: None; X. Juanola: None; A. Escudero-Contreras: None; J. Vázquez Mellado: None; I. Arias-de la Rosa: None; E. Collantes-Estevez: None; C. López Medina: AbbVie, 2, 5, 6, Eli Lilly, 2, 5, 6, Janssen, 6, MSD, 6, Novartis, 2, 5, 6, UCB Pharma, 2, 5, 6.

To cite this abstract in AMA style:

Puche-Larrubia M, Ladehesa-Pineda M, Font P, Burgos Vargas R, Sampaio-Barros P, Maldonado Cocco J, Barcelos A, Gratacos Masmitja J, Juanola X, Escudero-Contreras A, Vázquez Mellado J, Arias-de la Rosa I, Collantes-Estevez E, López Medina C. Clinical Expression of Radiographic Axial Spondyloarthritis and Its Association with HLA-B27 in European and Ibero-American Populations: Data from the REGISPONSER and RESPONDIA Registries [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/clinical-expression-of-radiographic-axial-spondyloarthritis-and-its-association-with-hla-b27-in-european-and-ibero-american-populations-data-from-the-regisponser-and-respondia-registries/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/clinical-expression-of-radiographic-axial-spondyloarthritis-and-its-association-with-hla-b27-in-european-and-ibero-american-populations-data-from-the-regisponser-and-respondia-registries/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology